275 related articles for article (PubMed ID: 29359812)
1. Novel insights into the disease dynamics of B-cell lymphomas in the Genomics Era.
Chan FC; Lim E; Kridel R; Steidl C
J Pathol; 2018 Apr; 244(5):598-609. PubMed ID: 29359812
[TBL] [Abstract][Full Text] [Related]
2. The emerging significance of secondary germline testing in cancer genomics.
Mandelker D; Zhang L
J Pathol; 2018 Apr; 244(5):610-615. PubMed ID: 29293272
[TBL] [Abstract][Full Text] [Related]
3. Genomic classifications of renal cell carcinoma: a critical step towards the future application of personalized kidney cancer care with pan-omics precision.
Hsieh JJ; Le V; Cao D; Cheng EH; Creighton CJ
J Pathol; 2018 Apr; 244(5):525-537. PubMed ID: 29266437
[TBL] [Abstract][Full Text] [Related]
4. The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses.
McAlpine J; Leon-Castillo A; Bosse T
J Pathol; 2018 Apr; 244(5):538-549. PubMed ID: 29344951
[TBL] [Abstract][Full Text] [Related]
5. The molecular pathology of cancer: from pan-genomics to post-genomics.
Huntsman DG; Ladanyi M
J Pathol; 2018 Apr; 244(5):509-511. PubMed ID: 29436707
[TBL] [Abstract][Full Text] [Related]
6. The value of cell-free DNA for molecular pathology.
Stewart CM; Kothari PD; Mouliere F; Mair R; Somnay S; Benayed R; Zehir A; Weigelt B; Dawson SJ; Arcila ME; Berger MF; Tsui DW
J Pathol; 2018 Apr; 244(5):616-627. PubMed ID: 29380875
[TBL] [Abstract][Full Text] [Related]
7. Genetic and epigenetic determinants of B-cell lymphoma evolution.
Izzo F; Landau DA
Curr Opin Hematol; 2016 Jul; 23(4):392-401. PubMed ID: 27135978
[TBL] [Abstract][Full Text] [Related]
8. Established, emerging and elusive molecular targets in the treatment of lung cancer.
Gallant JN; Lovly CM
J Pathol; 2018 Apr; 244(5):565-577. PubMed ID: 29344953
[TBL] [Abstract][Full Text] [Related]
9. PanCancer insights from The Cancer Genome Atlas: the pathologist's perspective.
Cooper LA; Demicco EG; Saltz JH; Powell RT; Rao A; Lazar AJ
J Pathol; 2018 Apr; 244(5):512-524. PubMed ID: 29288495
[TBL] [Abstract][Full Text] [Related]
10. Advances for studying clonal evolution in cancer.
Ding L; Raphael BJ; Chen F; Wendl MC
Cancer Lett; 2013 Nov; 340(2):212-9. PubMed ID: 23353056
[TBL] [Abstract][Full Text] [Related]
11. Clear cell carcinomas of the ovary and kidney: clarity through genomics.
Ji JX; Wang YK; Cochrane DR; Huntsman DG
J Pathol; 2018 Apr; 244(5):550-564. PubMed ID: 29344971
[TBL] [Abstract][Full Text] [Related]
12. Circulating Tumor DNA to Monitor Therapy for Aggressive B-Cell Lymphomas.
Kwok M; Wu SP; Mo C; Summers T; Roschewski M
Curr Treat Options Oncol; 2016 Sep; 17(9):47. PubMed ID: 27461036
[TBL] [Abstract][Full Text] [Related]
13. Genetic background and evolution of relapses in aggressive B-cell lymphomas.
Juskevicius D; Dirnhofer S; Tzankov A
Haematologica; 2017 Jul; 102(7):1139-1149. PubMed ID: 28554945
[TBL] [Abstract][Full Text] [Related]
14. Applications of Genomic Sequencing in Pediatric CNS Tumors.
Bavle AA; Lin FY; Parsons DW
Oncology (Williston Park); 2016 May; 30(5):411-23. PubMed ID: 27188671
[TBL] [Abstract][Full Text] [Related]
15. Pathology of B-cell lymphomas: diagnosis and biomarker discovery.
Ondrejka SL; Hsi ED
Cancer Treat Res; 2015; 165():27-50. PubMed ID: 25655605
[TBL] [Abstract][Full Text] [Related]
16. VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma.
Jiang Y; Nie K; Redmond D; Melnick AM; Tam W; Elemento O
J Vis Exp; 2015 Dec; (106):e53215. PubMed ID: 26780364
[TBL] [Abstract][Full Text] [Related]
17. Predictive genomics: a cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data.
Wang E; Zaman N; Mcgee S; Milanese JS; Masoudi-Nejad A; O'Connor-McCourt M
Semin Cancer Biol; 2015 Feb; 30():4-12. PubMed ID: 24747696
[TBL] [Abstract][Full Text] [Related]
18. Ethical considerations for modern molecular pathology.
Vos S; van Diest PJ; Ausems MG; van Dijk MR; de Leng WW; Bredenoord AL
J Pathol; 2018 Dec; 246(4):405-414. PubMed ID: 30125358
[TBL] [Abstract][Full Text] [Related]
19. Genomic signatures in B-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?
Iqbal J; Naushad H; Bi C; Yu J; Bouska A; Rohr J; Chao W; Fu K; Chan WC; Vose JM
Blood Rev; 2016 Mar; 30(2):73-88. PubMed ID: 26432520
[TBL] [Abstract][Full Text] [Related]
20. Tumor Evolution, Heterogeneity, and Therapy for Our Patients With Advanced Cancer: How Far Have We Come?
El-Deiry WS; Taylor B; Neal JW
Am Soc Clin Oncol Educ Book; 2017; 37():e8-e15. PubMed ID: 28746017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]